GAFFX | QALGX | GAFFX / QALGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 19 years | - |
Gain YTD | 3.129 | 2.447 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1500 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304B | 2.42B | 12,546% |
Annual Yield % from dividends | 0.75 | 0.00 | - |
Returns for 1 year | 12.76 | 21.14 | 60% |
Returns for 3 years | 24.03 | 41.16 | 58% |
Returns for 5 years | 44.22 | 55.13 | 80% |
Returns for 10 years | N/A | 91.15 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 30.44 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology Z | |||
VGICX | 70.62 | -0.93 | -1.30% |
JPMorgan US Value C | |||
WIISX | 12.89 | -0.18 | -1.38% |
William Blair International Sm Cap Gr R6 | |||
LYRZX | 12.07 | -0.17 | -1.39% |
Lyrical International Value Equity C | |||
HBSGX | 26.20 | -0.98 | -3.61% |
Hartford Small Cap Growth HLS IB |